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Background: Cardiac Resynchronization Therapy (CRT) is effective at improving functional status, heart failure (HF) symptoms and reducing 
mortality. Improvement in cardiac function is a marker of CRT response, but the relationship of reverse remodeling to long-term mortality is not well-
understood.
methods: The REVERSE study randomized 419 patients with NYHA I/II HF to CRT ON with a prospectively planned long-term follow-up phase. Of 
these patients, 353 had paired left ventricular end systolic volume index (LVESVi) measurements at baseline and 6 months post-implant. Subjects 
were grouped by LVESVi change to examine mortality rates. Additionally, LVESVi change was treated as a continuous variable in Cox proportional 
hazards models, first independently, then with baseline covariates.
results: Patients in whom LVESVi decreased > 15% at 6 months had a 6.9% mortality rate at four years. This was significantly lower than the 
16.4% mortality rate among patients with < 15% reduction. The change in LVESVi was a significant predictor of mortality (p<0.0001) as a 10% 
decrease in LVESVi corresponds to a 13% decrease in mortality risk. Multi-variable analysis showed that less reduction in LVESVi, male gender, 
higher baseline LVESVi, and shorter QRS duration were independent predictors of mortality (table).
conclusions:  LVESVi change with CRT is a strong predictor of long-term survival in mild heart failure. Very low mortality rates (1-2% per year) were 
observed in the presence of large reductions of LVESVi.
